Literature DB >> 22173070

Visual function 5 years or more after macular translocation surgery for myopic choroidal neovascularisation and age-related macular degeneration.

K Takeuchi1, S Kachi, E Iwata, K Ishikawa, H Terasaki.   

Abstract

PURPOSE: To evaluate the changes in the best-corrected visual acuity (BCVA) after 1 year and after ≥ 5 years after macular translocation for age-related macular degeneration (AMD) or myopic choroidal neovascularisation (mCNV).
METHODS: The medical records of 61 consecutive patients who underwent macular translocation with 360° retinotomy for AMD (35 eyes) or mCNV (26 eyes) were reviewed. Overall, 40 patients, 17 mCNV and 23 AMD, were followed for at least 5 years. BCVA and area of the Goldmann visual field (VF) measured before, 12 months after surgery, and at the final visit.
RESULTS: In the 23 AMD eyes followed for ≥ 5 years, the mean preoperative BCVA was 1.149 ± 0.105 logMAR units, which significantly improved to 0.69 ± 0.06 logMAR units at 1 year (P<0.001). This BCVA was maintained at 0.633 ± 0.083 logMAR units on their final examination. In the 17 eyes with mCNV followed for ≥ 5 years, the mean preoperative BCVA was 1.083 ± 0.119 logMAR units, which was significantly improved to 0.689 ± 0.121 logMAR units at 1 year (P = 0.001). This BCVA was maintained at 0.678 ± 0.142 logMAR units on their final examination. The area of the VF was significantly decreased at 12 months and did not change significantly thereafter.
CONCLUSIONS: Our results show that macular translocation surgery significantly improves the BCVA and significantly decreases the VF area of eyes with mCNV or AMD after first 1 year. The BCVA and VF area do not change significantly from the values at 1 year for at least 5 years.

Entities:  

Mesh:

Year:  2011        PMID: 22173070      PMCID: PMC3259604          DOI: 10.1038/eye.2011.302

Source DB:  PubMed          Journal:  Eye (Lond)        ISSN: 0950-222X            Impact factor:   3.775


  24 in total

1.  Change in full-field ERGs after macular translocation surgery with 360 degrees retinotomy.

Authors:  Hiroko Terasaki; Yozo Miyake; Toshimitsu Suzuki; Takashi Niwa; Chang-Hua Piao; Satoshi Suzuki; Makoto Nakamura; Mineo Kondo
Journal:  Invest Ophthalmol Vis Sci       Date:  2002-02       Impact factor: 4.799

2.  Comparison of three techniques of foveal translocation in patients with subfoveal choroidal neovascularization resulting from age-related macular degeneration.

Authors:  M Ohji; T Fujikado; S Kusaka; A Hayashi; J Hosohata; Y Ikuno; M Sawa; A Kubota; N Hashida; Y Tano
Journal:  Am J Ophthalmol       Date:  2001-12       Impact factor: 5.258

3.  Reading ability after macular translocation surgery with 360-degree retinotomy.

Authors:  Takashi Fujikado; Sanae Asonuma; Masahito Ohji; Shunji Kusaka; Atsushi Hayashi; Yasushi Ikuno; Motohiro Kamei; Koichi Oda; Yasuo Tano
Journal:  Am J Ophthalmol       Date:  2002-12       Impact factor: 5.258

4.  Macular translocation with 360 degree retinotomy for management of age-related macular degeneration with subfoveal choroidal neovascularization.

Authors:  Grazia Pertile; Carl Claes
Journal:  Am J Ophthalmol       Date:  2002-10       Impact factor: 5.258

5.  Visual outcomes following macular translocation with 360-degree peripheral retinectomy.

Authors:  James C Lai; Deborah J Lapolice; Sandra S Stinnett; Carsten H Meyer; Luz M Arieu; Melissa A Keller; Cynthia A Toth
Journal:  Arch Ophthalmol       Date:  2002-10

6.  Improvement in near visual function after macular translocation surgery with 360-degree peripheral retinectomy.

Authors:  Cynthia A Toth; Deborah J Lapolice; Avie D Banks; Sandra S Stinnett
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2004-06-05       Impact factor: 3.117

7.  One year follow up of macular translocation with 360 degree retinotomy in patients with age related macular degeneration.

Authors:  A Abdel-Meguid; A Lappas; K Hartmann; F Auer; N Schrage; G Thumann; B Kirchhof
Journal:  Br J Ophthalmol       Date:  2003-05       Impact factor: 4.638

8.  Change in visual function after macular translocation with 360 degrees retinectomy for neovascular age-related macular degeneration.

Authors:  Prithvi Mruthyunjaya; Sandra S Stinnett; Cynthia A Toth
Journal:  Ophthalmology       Date:  2004-09       Impact factor: 12.079

9.  Changes in focal macular ERGs after macular translocation surgery with 360 degrees retinotomy.

Authors:  Hiroko Terasaki; Kohei Ishikawa; Yasuhiro Niwa; Chang-Hua Piao; Takashi Niwa; Mineo Kondo; Yasuki Ito; Yozo Miyake
Journal:  Invest Ophthalmol Vis Sci       Date:  2004-02       Impact factor: 4.799

10.  Morphologic and angiographic assessment of the macula after macular translocation surgery with 360 degrees retinotomy.

Authors:  Hiroko Terasaki; Kohei Ishikawa; Toshimitsu Suzuki; Makoto Nakamura; Kensaku Miyake; Yozo Miyake
Journal:  Ophthalmology       Date:  2003-12       Impact factor: 12.079

View more
  10 in total

1.  Displacement of foveal area toward optic disc after macular hole surgery with internal limiting membrane peeling.

Authors:  K Kawano; Y Ito; M Kondo; K Ishikawa; S Kachi; S Ueno; Y Iguchi; H Terasaki
Journal:  Eye (Lond)       Date:  2013-05-24       Impact factor: 3.775

Review 2.  Anti-vascular endothelial growth factor for choroidal neovascularisation in people with pathological myopia.

Authors:  Ying Zhu; Ting Zhang; Gezhi Xu; Lijun Peng
Journal:  Cochrane Database Syst Rev       Date:  2016-12-15

3.  The role of indocyanine green angiography imaging in further differential diagnosis of patients with nAMD who are morphologically poor responders to ranibizumab in a real-life setting.

Authors:  A Ozkaya; C Alagoz; R Garip; Z Alkin; I Perente; A T Yazici; M Taskapili
Journal:  Eye (Lond)       Date:  2016-04-15       Impact factor: 3.775

4.  Dysregulated claudin-5 cycling in the inner retina causes retinal pigment epithelial cell atrophy.

Authors:  Natalie Hudson; Lucia Celkova; Alan Hopkins; Chris Greene; Federica Storti; Ema Ozaki; Erin Fahey; Sofia Theodoropoulou; Paul F Kenna; Marian M Humphries; Annie M Curtis; Eleanor Demmons; Akeem Browne; Shervin Liddie; Matthew S Lawrence; Christian Grimm; Mark T Cahill; Pete Humphries; Sarah L Doyle; Matthew Campbell
Journal:  JCI Insight       Date:  2019-08-08

Review 5.  Ocular stem cells: a narrative review of current clinical trials.

Authors:  Konstadinos Sotiropulos; Dimitrios Kourkoutas; Diamantis Almaliotis; Katherine Ploumidou; Vasileios Karampatakis
Journal:  Int J Ophthalmol       Date:  2022-09-18       Impact factor: 1.645

6.  Prospects for clinical use of reprogrammed cells for autologous treatment of macular degeneration.

Authors:  Ana Belen Alvarez Palomo; Samuel McLenachan; Fred K Chen; Lyndon Da Cruz; Rodney J Dilley; Jordi Requena; Michaela Lucas; Andrew Lucas; Micha Drukker; Michael J Edel
Journal:  Fibrogenesis Tissue Repair       Date:  2015-05-15

Review 7.  Stem cell therapies for age-related macular degeneration: the past, present, and future.

Authors:  Yalong Dang; Chun Zhang; Yu Zhu
Journal:  Clin Interv Aging       Date:  2015-01-14       Impact factor: 4.458

8.  Long-term results after limited macular translocation surgery for wet age-related macular degeneration.

Authors:  Hisaaki Oshima; Takeshi Iwase; Kohei Ishikawa; Kentaro Yamamoto; Hiroko Terasaki
Journal:  PLoS One       Date:  2017-05-23       Impact factor: 3.240

Review 9.  Tamponade or filling effect: changes of forces in myopic eyes.

Authors:  Francesco Semeraro; Francesco Morescalchi; Andrea Russo; Mario R Romano; Ciro Costagliola
Journal:  Biomed Res Int       Date:  2014-07-02       Impact factor: 3.411

Review 10.  Stem cells in regenerative medicine - from laboratory to clinical application - the eye.

Authors:  Anna M Dąbrowska; Piotr Skopiński
Journal:  Cent Eur J Immunol       Date:  2017-08-08       Impact factor: 2.085

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.